| 10428034 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors |
Christopher Ryan Butler, Laura Ann McAllister, Elizabeth Mary Beck, Michael Aaron Brodney, Adam Matthew Gilbert +6 more |
2019-10-01 |
| 10328082 |
Methods of use and combinations |
Eugene Lvovich Piatnitski Chekler, Adam Matthew Gilbert, Rayomand Jal Unwalla, James Thomas Anderson |
2019-06-25 |
| 10329308 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors |
Michael Aaron Brodney, Christopher Ryan Butler, Laura Ann McAllister, Christopher John Helal, Steven Victor O'Neil |
2019-06-25 |
| 10323042 |
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds |
Thomas Allen Chappie, Nandini Chaturbhai Patel, Christopher John Helal, Simone Sciabola, Erik Alphie LaChapelle +2 more |
2019-06-18 |
| 10316021 |
Heteroarylphenoxy benzamide kappa opioid ligands |
Natasha Mariam Kablaoui, Michael Eric Green, Justin Ian Montgomery, Michael Aaron Brodney, Gregory Wayne Kauffman +5 more |
2019-06-11 |
